» Articles » PMID: 17295657

Inflammation As a Risk Factor for Carotid Intimal-medial Thickening, a Measure of Subclinical Atherosclerosis in Haemodialysis Patients: the Role of Chlamydia and Cytomegalovirus Infection

Overview
Specialty Nephrology
Date 2007 Feb 14
PMID 17295657
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Atherosclerotic vascular disease is the most frequent complication seen in haemodialysis (HD) patients. Evidence suggests that inflammation may play a role in the pathogenesis and progression of atherosclerosis. Our aim was to evaluate the causative role of inflammation in atherosclerosis among HD patients.

Methods: Intima-media thickness (IMT) in carotid arteries was determined in 54 HD patients and 52 controls. Plasma levels of lipids, glucose, albumin and several acute phase proteins, and immunoglobulin G titres against chlamydia and cytomegalovirus were measured in all subjects.

Results: Mean carotid IMT was significantly greater in HD patients than in controls (0.75 mm vs 0.56 mm, P < 0.005). While plasma levels of C-reactive protein (CRP), serum amyloid A (SAA), lipoprotein (a) Lp(a), fibrinogen and ferritin were higher in HD patients, albumin levels were lower. In HD patients, carotid IMT was correlated positively with CRP (R = 0.29, P = 0.019), SAA (R = 0.69, P < 0.001), Lp(a) (R = 0.42, P = 0.001), fibrinogen (R = 0.57, P < 0.001) and chlamydia pneumonia immunoglobulin G titres (R = 0.50, P < 0.001), and negatively with albumin levels (R = -0.33, P = 0.02); there was no relationship between carotid IMT and hypertension, plasma lipid levels and cytomegalovirus. In multivariate regression analysis, these variables still showed a significant relationship with IMT (R(2) = 0.694 and P < 0.001).

Conclusion: We conclude that atherosclerotic changes are more common in HD patients than in controls, and that inflammatory processes may play a role in the pathogenesis of atherosclerosis.

Citing Articles

Transradial intervention in dialysis patients undergoing percutaneous coronary intervention: a Japanese nationwide registry study.

Kuno T, Yamaji K, Aikawa T, Sawano M, Ando T, Numasawa Y Eur Heart J Open. 2023; 3(6):oead116.

PMID: 38105921 PMC: 10721448. DOI: 10.1093/ehjopen/oead116.


Cardiovascular Calcifications Are Correlated with Inflammation in Hemodialysis Patients.

Dragos D, Timofte D, Georgescu M, Manea M, Vacaroiu I, Ionescu D Medicina (Kaunas). 2023; 59(10).

PMID: 37893519 PMC: 10608311. DOI: 10.3390/medicina59101801.


Serum Endocan Levels and Subclinical Atherosclerosis in Patients with Chronic Kidney and End-Stage Renal Diseases.

El-Senosy F, Abd El Aziz R, Kasim S, Gad L, Hassan D, Sabry S Int J Clin Pract. 2022; 2022:4524637.

PMID: 35936065 PMC: 9300358. DOI: 10.1155/2022/4524637.


T-cell aging in end-stage renal disease: an evolving story with CMV.

Yang T, Chuang Y, Chiu Y Med Microbiol Immunol. 2019; 208(3-4):281-287.

PMID: 30903371 DOI: 10.1007/s00430-019-00596-8.


Trans-radial percutaneous coronary intervention for patients with severe chronic renal insufficiency and/or on dialysis.

Kuno T, Hirano K, Abe T, Imaeda S, Hashimoto K, Ryuzaki T Heart Vessels. 2019; 34(9):1412-1419.

PMID: 30903313 DOI: 10.1007/s00380-019-01387-0.